Patents by Inventor Conrad M. Swartz

Conrad M. Swartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080188905
    Abstract: A method of treating a patient includes administering an electroconvulsive therapy (ECT) stimulus to the patient. The current is greater than about 0.9 ampere or 1.0 ampere, or is between about 1.0 and about 2 amperes. The energy delivered is about 100 Joules or less across an impedance of 200 ohms. The stimulus may have a pulsewidth between about 0.5 and about 2.0 msec and/or a frequency in the range of about 10 to about 180 Hz, or the stimulus may have a pulsewidth between about 0.2 and about 0.499 msec and/or a frequency in the range of about 15 to about 300 Hz. An apparatus for ECT comprises a generator adapted to deliver such an electroconvulsive therapy stimulus to a patient. A method of calculating ECT dose comprises multiplying a charge to be delivered by the current (or voltage) to an exponential power between 2 and 4.
    Type: Application
    Filed: February 2, 2007
    Publication date: August 7, 2008
    Applicant: SOMATICS LLC
    Inventor: Conrad M. Swartz
  • Patent number: 6365618
    Abstract: The compound carvedilol has the chemical formula: ñ-1-(carbazol-4-yloxy)-3-[[2-(o-methyoxyphenoxy)ethyl]amino]-2-propanol. It exists in the form of optical isomers R- and S-carvedilol, and as mixtures of these isomers. It, or one of its optical isomers, is administered, preferably orally, several times per day in tablets of 3-25 mg for the treatment, prevention and clinical arrest of movement disorders associated with medications which block dopamine receptors, including many antipsychotic and antiemetic medications. Such movement disorders include tardive dyskinesia, tardive dystonia, and tardive akathisia. The compound carvedilol is also administered to improve the treatment of mental disorders in which dopamine-blocking medications are used, such as manic episodes, major depressive episodes, and psychoses such as schizophrenia and schizoaffective disorder.
    Type: Grant
    Filed: December 13, 2000
    Date of Patent: April 2, 2002
    Inventor: Conrad M. Swartz
  • Patent number: 5813970
    Abstract: A magnetic induction coil is placed next to the scalp of a patient. A pulse train of high energy electrical waves is flowed through the induction coil to produce a sufficiently strong magnetic field to generate currents in the patient's brain for the therapy of neurologic or psychiatric illnesses. These currents induced in the brain cause multifocal neuronal discharge to induce a generalized convulsive neuronal discharge.
    Type: Grant
    Filed: April 22, 1994
    Date of Patent: September 29, 1998
    Assignee: Somatics, Inc.
    Inventors: Richard S. Abrams, Conrad M. Swartz
  • Patent number: 5769778
    Abstract: A medical device includes a magnetic stimulator having a magnetic induction coil which is placed next to the scalp of a patient. A pulse train of high energy electrical waves is flowed through the induction coil to produce a sufficiently strong magnetic field to generate currents in the patient's brain for the therapy of psychiatric illnesses. These currents induced in the brain are below the minimum needed to induce a convulsive brain seizure. The device includes an ECG (electrocardiograph) to monitor the electrical activity of the patient's heart and an EEG (electroencephalograph) to monitor the patient's electrical brain waves.
    Type: Grant
    Filed: July 7, 1997
    Date of Patent: June 23, 1998
    Assignee: Somatics, Inc.
    Inventors: Richard S. Abrams, Conrad M. Swartz
  • Patent number: 5470347
    Abstract: An electronic method and apparatus in electroconvulsive therapy (ECT) to automatically measure the electrical dosage of an ECT device at the time of stimulus and to prevent delivery to the patient of a dosage that is substantially (e.g., more than 5%, or 25 millicoulombs [mC], or 5 joules [J]) larger than the dosage selected by the operator. When the measured dosage varies more or less than a selected limited amount, or proportion, from the stimulus dial setting (e.g., 5% or 25 mC or 5 J), visible and/or audible signals are triggered and the device is blocked from delivering further stimuli without first being reset.
    Type: Grant
    Filed: December 13, 1994
    Date of Patent: November 28, 1995
    Assignee: Somatics, Inc.
    Inventors: Conrad M. Swartz, Richard S. Abrams
  • Patent number: 5269302
    Abstract: In electroconvulsive therapy (ECT) the duration of the generated skeletal muscle, heart and brain wave activity during the administration of the electrically induced therapeutic seizures is automatically monitored. The ECT device includes a special purpose electromyograph (EMG) to detect isolated muscle activity and, in one embodiment, an electrocardiograph (ECG) to detect heart-beat intervals, and in another embodiment also includes an electroencephalograph (EEG) system to detect an EEG parameter of the electrically induced EEG seizure. The detected voltage from the EMG, ECG and EEG are converted to digital data and compared to a set of threshold reference values previously obtained from the same patient. The operator is informed by a display, or auditory signal, if the selected parameters have crossed the predetermined threshold reference value and the time period, since termination of the ECT that each parameter has taken to reach the reference value.
    Type: Grant
    Filed: May 6, 1992
    Date of Patent: December 14, 1993
    Assignee: Somatics, Inc.
    Inventors: Conrad M. Swartz, Richard S. Abrams
  • Patent number: 4878498
    Abstract: A method and systen in electroconvulsive therapy (ECT) to automatically monitor and display the occurrence and the duration of the seizure activity generated during the administration of electrically induced therapeutic seizures. The ECT device includes a special-purpose electroencephaloraph (EEG) system to detect a specific EEG parameter (e.g. integrated voltage) of the electrically induced EEG seizure. The detected integrated voltage is converted to digital data and compared to a threshold reference value previously obtained from the same patient. The operator is informed by an electronic alphanumeric elapsed time display or indications on a moving strip chart paper record, or oscilloscope CRT screen, when the parameter has crossed the predetermined threshold reference value and how long since the termination of the ECT the parameter has taken to reach the reference value.
    Type: Grant
    Filed: February 23, 1989
    Date of Patent: November 7, 1989
    Assignee: Somatics, Inc.
    Inventors: Richard Abrams, Conrad M. Swartz
  • Patent number: 4873981
    Abstract: A method and system in electroconvulsive therapy (ECT) to automatically monitor and display the occurrence and the duration of the seizure activity generated during the administration of the electrically induced therapeutic seizures. The ECT device includes a special-purpose electroencephalograph (EEG) system to detect a specific EEG parameter (e.g. integrated voltage) of the electrically induced EEG seizure. The detected integrated voltage is converted to digital data and compared to a threshold reference value previously obtained from the same patient. The operator is informed by an electronic alphanumeric elapsed time display or indications on a moving strip chart paper record, or oscilloscope CRT screen, when the parameter has crossed the predetermined threshold reference value and how long since the termination of the ECT the parameter has taken to reach the reference value.
    Type: Grant
    Filed: October 14, 1988
    Date of Patent: October 17, 1989
    Assignee: Somatics, Inc.
    Inventors: Richard Abrams, Conrad M. Swartz
  • Patent number: 4870969
    Abstract: A medical method and system in electroconvulsive therapy (ECT) uses a disposable electrode, which does not use a liquid, such as conductive gel or saline solution. The electrode is a flexible multi-layer pad having an adhesive surface which is covered by a removable cover sheet. The pad comprises a layer of adhesive non-liquid conductive hydrogel, a thin conductive plastic film layer, a conductive metal foil layer connected to a wire lead, and an insulative plastic layer, preferably a plastic foam.
    Type: Grant
    Filed: September 16, 1988
    Date of Patent: October 3, 1989
    Assignee: Somatics, Inc.
    Inventor: Conrad M. Swartz